Johnny Zou
Executive Director @ Primavera Capital Group
Johnny Zou is a Series A investor at Primavera Capital Group focused on Biotechnology and Medical. Johnny Zou is the Executive Director at Primavera Capital Group. He attended Yale University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Johnny Zou invests in
Stages Johnny Zou invests in
Countries Johnny Zou invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Pharmaceutical 1 (50%)
- Artificial Intelligence 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Analytical Biosciences
|
Analytical Biosciences is a single-cell genome developer that aims to create and apply accurate maps of human diseases. In collaboration with medical research institutions, hospitals, and pharmaceutical companies, we are committed to exploiting the application of single-cell genomics and bioinformatics in the diagnosis and treatment of humandiseases. Through large-scale systematic disease single-cell mapping, big data intelligence mining is carried out to help a wide range of partners discover new therapeutic targets and develop new treatment strategies. | Series A / May 26, 2021 | |
Xbiome
|
Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to morequickly develop effective pharmaceuticals. | Series B / Nov 27, 2020 |
Co-Investors
About Primavera Capital Group
Primavera Capital Group is a China-based global investment firm. With offices located in Beijing and Hong Kong, Primavera manages both RMB and USD funds for leading institutions, corporations, and families in China and around the world.Primavera Capital Group was founded by Dr. Fred Hu, a renowned economist and successful investor, and aformer partner and Chairman of Greater China at Goldman Sachs Group.The firm currently has 30+ investment professionals with an outstanding track record. The team combines global capital market experience, deep industry knowledge, and a unique network of relationships with policy-makers and regulators as well as leading CEOs and entrepreneurs in the region and globally.Primavera Capital Group puts great emphasis on rigorous fundamental research. The firm undertakes sophisticated analysis on economies, industries and companies to generate investment ideas, identify attractive opportunities, and guide its investment decisions.Primavera Capital Group employs a flexible investment strategy of growth capital, buy-out and control, and special situations - restructuring, distressed, and turn-arounds, etc.
Primavera Capital Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David Lin
Managing Director
|
|||
Fred Hu
Founder, Chairman & CEO
|
|||
|
Johnny Zou
Executive Director
|
|||
Dapeng Zhu
Managing Director
|
|||
William Wang
Founding Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Johnny Zou invest in?
Johnny Zou invests primarily in Biotechnology, Medical and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Johnny Zou last invest?
The most recent investment recorded for Johnny Zou closed in May 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
